Is Palantir Stock in a Bubble?
Shares of AI and data analytics giant Palantir (NASDAQ:PLTR) have…
Sell
34
APLM Quote, Financials, Valuation and Earnings
Last price:
$6.50
Seasonality move
:
-33.17%
Day range:
$7.20 - $8.00
52-week range:
$6.50 - $80.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.40x
Volume:
7.4K
Avg. volume:
17.7K
1-year change:
-89.11%
Market cap:
$8.2M
Revenue:
--
EPS (TTM):
-$15.00
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Apollomics has 2580.97% upside to fair value with a price target of -- per share.
APLM vs. S&P 500
-
Over the past 5 trading days, Apollomics has underperformed the S&P 500 by -14.62% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Apollomics does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Apollomics has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Apollomics reported revenues of --.
Earnings Growth
-
Apollomics has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Apollomics reported earnings per share of --.
Enterprise value:
-14.2M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
0.41x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-02-12 | 2024-02-12 | 2024-02-12 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $75.3M | $55.4M | $28.4M | |
| Total Assets | -- | -- | $99.5M | $71.4M | $34.6M | |
| Current Liabilities | -- | -- | $12.8M | $14.1M | $12.6M | |
| Total Liabilities | -- | -- | $312M | $15.7M | $13.8M | |
| Total Equity | -- | -- | -$212.5M | $55.7M | $20.8M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-02-12 | 2024-02-12 | 2024-02-12 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
APLM
Sector
Market Cap
$8.2M
$43.9M
Price % of 52-Week High
9.27%
47.62%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-89.11%
-34.83%
Beta (5-Year)
--
0.753
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$8.49
200-day SMA
Sell
Level
$17.05
Bollinger Bands (100)
Sell
Level
8.76 - 13.68
Chaikin Money Flow
Sell
Level
-164.5M
20-day SMA
Sell
Level
$9.13
Relative Strength Index (RSI14)
Sell
Level
34.19
ADX Line
Sell
Level
15.61
Williams %R
Buy
Level
-90.0763
50-day SMA
Sell
Level
$9.30
MACD (12, 26)
Sell
Level
-0.49
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Neutral
Level
61.1M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
Stock Forecast FAQ
In the current month, APLM has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The APLM average analyst price target in the past 3 months is --.
-
Where Will Apollomics Stock Be In 1 Year?
According to analysts, the consensus estimate is that Apollomics share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Apollomics?
Analysts are divided on their view about Apollomics share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Apollomics is a Sell and believe this share price will drop from its current level to --.
-
What Is Apollomics's Price Target?
The price target for Apollomics over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is APLM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Apollomics is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of APLM?
You can purchase shares of Apollomics via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Apollomics shares.
-
What Is The Apollomics Share Price Today?
Apollomics was last trading at $6.50 per share. This represents the most recent stock quote for Apollomics. Yesterday, Apollomics closed at $7.46 per share.
-
How To Buy Apollomics Stock Online?
In order to purchase Apollomics stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
5 Stocks Poised for Big Gains in 2025?
Alphabet (GOOGL) ended 2024 on a high note with AI…
Is Upstart Stock a Buy Sell or Hold?
Last year Upstart Holdings (NASDAQ:UPST) saw its valuation soar by…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 112x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
74
SWTX alert for Feb 11
SpringWorks Therapeutics [SWTX] is up 2.22% over the past day.
Sell
19
SMTC alert for Feb 11
Semtech [SMTC] is up 1.57% over the past day.
Buy
71
MNDY alert for Feb 11
Monday.Com [MNDY] is up 0.45% over the past day.
